SAB Biotherapeutics, Inc. (SABSW) NASDAQ

Currency In USD

SAB Biotherapeutics, Inc.

Address

2100 East 54th Street North

Sioux Falls, SD 33140

United States of America (the)

Phone

605-679-6980

Website

http://www.sabbiotherapeutics.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

October 25, 2021

Key Executives

Name	Title	Pay	Year Born
Samuel J. Reich	CEO & Director	846,462	1975
Christoph Bausch	Executive Vice President & Chief Operating Officer	609,000	1971
Lucy To	Executive Vice President & Chief Financial Officer	684,034	1986
Eddie Joe Sullivan	Co-Founder, President & Director	746,500	1967
Alexandra Kropotova	Executive Vice President & Chief Medical Officer	832,249	1973
Carlos N. Carillo	Senior Vice President of Regulatory Affairs	0	N/A
Angie Parizek	Senior Vice President of Clinical Operations	0	N/A
Catherine DeRose	Vice President of Human Resources	0	N/A
Cristi Barnett	Vice President of Investor Relations & Corporate Communications	0	N/A
Hua Wu	Senior Vice President of Product Development	0	N/A

Description

SAB Biotherapeutics, Inc. is a biopharmaceutical firm specializing in the development of immunotherapies. Their efforts are directed towards combating various health challenges, such as infectious and autoimmune diseases, as well as oncology. Among their notable therapeutic candidates are SAB-142, an anti-thymocyte globulin intended for Type 1 diabetes; SAB-176, which targets seasonal influenza; and SAB-301, developed to counter Middle East Respiratory Syndrome Coronavirus (MERS-COV). Founded in 2014, the company's headquarters are located in Sioux Falls, South Dakota, with a secondary office situated in Cambridge, Massachusetts.